For the second quarter ended September 30, 2024, Privy Speciality Chemicals showcased growth across several key financial metrics. The company’s revenue from operations grew 15% QoQ to ₹532.79 crore from ₹463.97 crore in Q1 FY25. On a year-on-year (YoY) basis, the revenue increased 16.9%, compared to ₹455.35 crore in Q2 FY24.
The net profit for Q2 FY25 stood at ₹48.43 crore, reflecting a 5.4% QoQ growth from ₹31.45 crore in Q1 FY25 and a YoY growth of 57.5%, from ₹30.28 crore in Q2 FY24.
Key Financial Highlights of Privy Speciality Chemicals Q2 FY25:
- Revenue from Operations: ₹532.79 crore in Q2 FY25, compared to ₹463.98 crore in Q1 FY25, reflecting a QoQ growth of 14.8%. YoY, it grew from ₹455.35 crore in Q2 FY24, a rise of 17%.
- Total Income: The company reported total income of ₹537.26 crore in Q2 FY25, up from ₹466.67 crore in Q1 FY25 and ₹462.33 crore in Q2 FY24.
-
Net Profit: Net profit after tax for Q2 FY25 stood at ₹44.84 crore, compared to ₹31.45 crore in Q1 FY25, representing a QoQ growth of 42.56%. YoY, net profit surged from ₹30.28 crore in Q2 FY24, a rise of 48.06%.
- Expenses: Total expenses for Q2 FY25 were ₹476.51 crore, up from ₹423.75 crore in Q1 FY25 and ₹421.95 crore in Q2 FY24, reflecting an increase in operational costs.
- EBITDA: The EBITDA saw healthy growth supported by increased revenue and operational efficiency.
This performance indicates the company’s steady growth, both in terms of revenue and profitability.
